News

Penn State Hershey Breast Center, Weis Markets partner on complementary mammogram initiative

BY Michael Johnsen

HERSHEY, Pa. — Penn State Hershey Breast Center and Weis Markets on Thursday announced a new partnership with the Pennsylvania Department of Health’s HealthyWoman Program to provide mammograms to women in need.

“This partnership with Weis Markets and the HealthyWoman Program means we can help remove one of the barriers to women scheduling a potentially lifesaving mammogram,” stated Susann Schetter, division chief of breast imaging at Penn State Hershey Breast Center. “Because we know that early detection is the key to better outcomes for women diagnosed with breast cancer, we’re proud to be able to offer this service to those at most need in our community.”

“We are extremely pleased to be supporting a long-term program that offers prospect of detecting early cancers and benefits women with little or no insurance,” commented Dennis Curtin, Weis Markets’ director of public relations. “We hope our partnership with Penn State Hershey Breast Center results in improved access throughout Central Pennsylvania to the Pennsylvania Department of Health’s HealthyWoman Program.”

The Weis Markets Mammography Voucher Program will provide vouchers for free mammograms to uninsured or underinsured women in central Pennsylvania. The vouchers will be made available through the HealthyWoman Program, a Department of Health initiative that provides free breast and cervical cancer screening to women with low to moderate income.

The Department of Health’s HealthyWoman Program offers mammograms and Pap tests, preventive care and treatment to women with low to moderate income at no cost. Women between the ages of 40 years and 64 years and who have limited or no health insurance may be eligible.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

DPP-IV inhibitors, GLP-1 analogues to see strongest growth among Type 2 diabetes drugs through 2020, study finds

BY Alaric DeArment

BURLINGTON, Mass. — Two classes of drugs for treating Type 2 diabetes will experience the biggest growth in market share of all classes of drugs for the condition, according to a new study by Decision Resources.

The study found that DPP-IV inhibitors and GLP-1 analogues would experience the biggest growth in market share among all drug classes, with a combined market share that will increase from 20% in 2010 to 47% in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The report found that Merck & Co.’s Januvia (sitagliptin) dominates DPP-IV drugs and will consolidate its position, while GLP-1 analogues will have a strong position as well, with Novo Nordisk’s Victoza (liraglutide) having the opportunity to edge up due to delays in the launch of Bydureon (exenatide), a once-weekly GLP-1 analogue made by Eli Lily & Co., Amylin Pharmaceuticals and Alkermes.

 


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Inspiring young Latinos to join healthcare field comes at critical time

BY Antoinette Alexander

WHAT IT MEANS AND WHY IT’S IMPORTANT — The news that CVS Caremark has partnered with the Hispanic Heritage Foundation to inspire and prepare young Latinos to join the healthcare field is not only positive in its own right but is especially important when you look at the fact that the nation’s Hispanic population is growing four times faster than the total U.S. population.

(THE NEWS: CVS Caremark, Hispanic Heritage Foundation partner to inspire future Latino healthcare leaders. For the full story, click here)

As the article states, through a new healthcare category of the HHF Youth Awards program, CVS Caremark and HHF will recognize this fall and winter more than 30 high school seniors of Latino descent for their academic performance, community service and interest in pursuing a career in health care.

Providing opportunities for career development and aiming to bolster the number of young Latinos pursuing traditional and nontraditional healthcare careers is essential. According to the U.S. Census Bureau, between 2000 and 2010, the Hispanic population grew by 43% — four times the nation’s 9.7% growth rate. The Hispanic population grew in every region of the United States between 2000 and 2010, with the most significant growth occurring in the South (a 57% increase) and the Midwest (a 49% increase), according to the U.S. Census Bureau. While the Hispanic population grew at a slower rate in the West and Northeast, the regions still saw significant growth. The Hispanic population in the West grew by 34% and by 33% in the Northeast.

Furthermore, a September 2011 special report by IBISWorld on the growing Hispanic population stated that over the next five years to 2016, the Hispanic contribution to the colleges and universities industry is projected to grow at an average annual rate of 5.1% to $44 billion. "Institutional and government programs that promote minority and low-income college attainment will continue to boost the Hispanic contribution to higher education," the report noted.

Clearly, the Hispanic population is a vital market. Now, factor in the fact that some 32 million uninsured will gain coverage beginning in 2014, amid an ongoing primary care physician shortage. The U.S. healthcare system already is overflowing, and finding ways to encourage youth to pursue careers in health care is critical.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?